Articles published by Aarvik Therapeutics

Aarvik Therapeutics Showcases Novel ADC Molecules Based On MUTTA™ and AQUALINK™ Platforms at AACR 2026

March 17, 2026

From Aarvik Therapeutics

Via Business Wire

Aarvik Therapeutics Announces Investment by Laurus Labs in Aarvik Series Seed 2 Round

October 08, 2025

From Aarvik Therapeutics

Via Business Wire

Aarvik Therapeutics Announces Successful Series Seed 2 Financing Round

September 29, 2025

From Aarvik Therapeutics

Via Business Wire

Aarvik Therapeutics Announces Option Exercise by Collaboration Partner ArriVent BioPharma

August 15, 2024

From Aarvik Therapeutics

Via Business Wire

Aarvik Therapeutics Announces a Global Novel Payload Agreement with NJ Bio, Inc.

December 07, 2022

From Aarvik Therapeutics

Via Business Wire

Aarvik Therapeutics Announces Validation of Novel Tetravalent Antibody Platform

August 19, 2022

From Aarvik Therapeutics

Via Business Wire

Aarvik Therapeutics Appoints Dr. Richard Scheller to Board of Directors, Dr. Melissa Starovasnik to Scientific Advisory Board, and Announces Scientific Team

September 23, 2021

From Aarvik Therapeutics

Via Business Wire

Aarvik Therapeutics (formerly Aarkus Therapeutics) Announces Successful Series Seed Financing

August 23, 2021

From Aarvik Therapeutics

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.